These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 18288972)

  • 1. HIV-1 neutralizing activity is correlated with increased levels of chemokines in saliva of HIV-1-exposed uninfected individuals.
    Hirbod T; Reichard C; Hasselrot K; Söderlund J; Kimani J; Bwayo JJ; Plummer F; Kaul R; Broliden K
    Curr HIV Res; 2008 Jan; 6(1):28-33. PubMed ID: 18288972
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HIV-1 exposed uninfected men who have sex with men have increased levels of salivary CC-chemokines associated with sexual behavior.
    Hasselrot K; Bratt G; Duvefelt K; Hirbod T; Sandström E; Broliden K
    AIDS; 2010 Jun; 24(10):1569-75. PubMed ID: 20549845
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mucosal and plasma IgA from HIV-exposed seronegative individuals neutralize a primary HIV-1 isolate.
    Devito C; Hinkula J; Kaul R; Lopalco L; Bwayo JJ; Plummer F; Clerici M; Broliden K
    AIDS; 2000 Sep; 14(13):1917-20. PubMed ID: 10997395
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cross-clade HIV-1-specific neutralizing IgA in mucosal and systemic compartments of HIV-1-exposed, persistently seronegative subjects.
    Devito C; Hinkula J; Kaul R; Kimani J; Kiama P; Lopalco L; Barass C; Piconi S; Trabattoni D; Bwayo JJ; Plummer F; Clerici M; Broliden K
    J Acquir Immune Defic Syndr; 2002 Aug; 30(4):413-20. PubMed ID: 12138348
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Divergent regulation of HIV-1 replication in PBMC of infected individuals by CC chemokines: suppression by RANTES, MIP-1alpha, and MCP-3, and enhancement by MCP-1.
    Vicenzi E; Alfano M; Ghezzi S; Gatti A; Veglia F; Lazzarin A; Sozzani S; Mantovani A; Poli G
    J Leukoc Biol; 2000 Sep; 68(3):405-12. PubMed ID: 10985258
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral HIV-exposure elicits mucosal HIV-neutralizing antibodies in uninfected men who have sex with men.
    Hasselrot K; Säberg P; Hirbod T; Söderlund J; Ehnlund M; Bratt G; Sandström E; Broliden K
    AIDS; 2009 Jan; 23(3):329-33. PubMed ID: 19114861
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cervicovaginal levels of lactoferrin, secretory leukocyte protease inhibitor, and RANTES and the effects of coexisting vaginoses in human immunodeficiency virus (HIV)-seronegative women with a high risk of heterosexual acquisition of HIV infection.
    Novak RM; Donoval BA; Graham PJ; Boksa LA; Spear G; Hershow RC; Chen HY; Landay A
    Clin Vaccine Immunol; 2007 Sep; 14(9):1102-7. PubMed ID: 17671228
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional HIV-1 specific IgA antibodies in HIV-1 exposed, persistently IgG seronegative female sex workers.
    Broliden K; Hinkula J; Devito C; Kiama P; Kimani J; Trabbatoni D; Bwayo JJ; Clerici M; Plummer F; Kaul R
    Immunol Lett; 2001 Nov; 79(1-2):29-36. PubMed ID: 11595287
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Salivary basic proline-rich proteins are elevated in HIV-exposed seronegative men who have sex with men.
    Burgener A; Mogk K; Westmacott G; Plummer F; Ball B; Broliden K; Hasselrot K
    AIDS; 2012 Sep; 26(15):1857-67. PubMed ID: 22824632
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spontaneous and antigen-induced chemokine production in exposed but uninfected partners of HIV type 1-infected individuals in North India.
    Suresh P; Wanchu A; Bhatnagar A; Sachdeva RK; Sharma M
    AIDS Res Hum Retroviruses; 2007 Feb; 23(2):261-8. PubMed ID: 17331032
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of human immunodeficiency virus type 1-specific inhibitory activities in saliva and other human mucosal fluids.
    Kazmi SH; Naglik JR; Sweet SP; Evans RW; O'Shea S; Banatvala JE; Challacombe SJ
    Clin Vaccine Immunol; 2006 Oct; 13(10):1111-8. PubMed ID: 16928883
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Natural killer cells from human immunodeficiency virus (HIV)-infected individuals are an important source of CC-chemokines and suppress HIV-1 entry and replication in vitro.
    Oliva A; Kinter AL; Vaccarezza M; Rubbert A; Catanzaro A; Moir S; Monaco J; Ehler L; Mizell S; Jackson R; Li Y; Romano JW; Fauci AS
    J Clin Invest; 1998 Jul; 102(1):223-31. PubMed ID: 9649576
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IgA immunity in HIV type 1-infected chimpanzees. II. Mucosal immunity.
    Black KP; Fultz PN; Girard M; Jackson S
    AIDS Res Hum Retroviruses; 1997 Oct; 13(15):1273-82. PubMed ID: 9339844
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIV-neutralizing immunoglobulin A and HIV-specific proliferation are independently associated with reduced HIV acquisition in Kenyan sex workers.
    Hirbod T; Kaul R; Reichard C; Kimani J; Ngugi E; Bwayo JJ; Nagelkerke N; Hasselrot K; Li B; Moses S; ; MacDonald KS; Broliden K
    AIDS; 2008 Mar; 22(6):727-35. PubMed ID: 18356602
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced secretory leukocyte protease inhibitor in human immunodeficiency virus type 1-infected patients.
    Baqui AA; Meiller TF; Falkler WA
    Clin Diagn Lab Immunol; 1999 Nov; 6(6):808-11. PubMed ID: 10548568
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HIV-1-Neutralizing IgA Detected in Genital Secretions of Highly HIV-1-Exposed Seronegative Women on Oral Preexposure Prophylaxis.
    Lund JM; Broliden K; Pyra MN; Thomas KK; Donnell D; Irungu E; Muwonge TR; Mugo N; Manohar M; Jansson M; Mackelprang R; Marzinke MA; Baeten JM; Lingappa JR
    J Virol; 2016 Nov; 90(21):9855-9861. PubMed ID: 27558421
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Salivary human immunodeficiency virus (HIV)-1-specific immunoglobulin A in HIV-1-exposed infants in Kenya.
    Farquhar C; VanCott T; Bosire R; Bermudez C; Mbori-Ngacha D; Lohman-Payne B; Nduati R; Otieno P; John-Stewart G
    Clin Exp Immunol; 2008 Jul; 153(1):37-43. PubMed ID: 18505437
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spontaneous production of C-C chemokines by individuals infected with human T lymphotropic virus type II (HTLV-II) alone and HTLV-II/HIV-1 coinfected individuals.
    Lewis MJ; Gautier VW; Wang XP; Kaplan MH; Hall WW
    J Immunol; 2000 Oct; 165(7):4127-32. PubMed ID: 11034425
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nitric oxide regulates MIP-1alpha expression in primary macrophages and T lymphocytes: implications for anti-HIV-1 response.
    Sherry B; Schmidtmayerova H; Zybarth G; Dubrovsky L; Raabe T; Bukrinsky M
    Mol Med; 2000 Jun; 6(6):542-9. PubMed ID: 10972089
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neutralization of human immunodeficiency virus type 1 (HIV-1) mediated by parotid IgA of HIV-1-infected patients.
    Moja P; Tranchat C; Tchou I; Pozzetto B; Lucht F; Desgranges C; Genin C
    J Infect Dis; 2000 May; 181(5):1607-13. PubMed ID: 10823760
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.